Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.

A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation.

Vanderbilt's Michael Fowler, MD, associate professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, a celebrated Master Clinical Teacher, and co-medical director of the Shade Tree Clinic, died Feb. 20. He was 49.

Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications.

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.

In a randomized controlled trial, vitamin D supplementation did not improve biomarkers for cardiovascular and metabolic disease.